WuXi Biologics (Cayman) (HKSE:02269) Market Cap : HK$58,111 Mil (As of Apr. 29, 2024)

View and export this data going back to 2017. Start your Free Trial

What is WuXi Biologics (Cayman) Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). WuXi Biologics (Cayman)'s share price for the quarter that ended in Jun. 2023 was HK$37.55. WuXi Biologics (Cayman)'s Shares Outstanding (EOP) for the quarter that ended in Jun. 2023 was 4,249 Mil. Therefore, WuXi Biologics (Cayman)'s market cap for the quarter that ended in Jun. 2023 was HK$159,532 Mil.

WuXi Biologics (Cayman)'s quarterly market cap declined from Jun. 2022 (HK$306,121 Mil) to Dec. 2022 (HK$252,882 Mil) and declined from Dec. 2022 (HK$252,882 Mil) to Jun. 2023 (HK$159,532 Mil).

WuXi Biologics (Cayman)'s annual market cap declined from Dec. 2020 (HK$416,646 Mil) to Dec. 2021 (HK$394,170 Mil) and declined from Dec. 2021 (HK$394,170 Mil) to Dec. 2022 (HK$252,882 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. WuXi Biologics (Cayman)'s Enterprise Value for Today is HK$48,892 Mil.

WuXi Biologics (Cayman) Market Cap Historical Data

The historical data trend for WuXi Biologics (Cayman)'s Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

WuXi Biologics (Cayman) Market Cap Chart

WuXi Biologics (Cayman) Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Market Cap

Get a 7-Day Free Trial

127,692.11

416,645.52

394,170.45

252,881.81

126,022.00

WuXi Biologics (Cayman) Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Market Cap	Get a 7-Day Free Trial													394,170.45	306,121.45	252,881.81	159,532.30	126,022.00

Competitive Comparison of WuXi Biologics (Cayman)'s Market Cap

For the Biotechnology subindustry, WuXi Biologics (Cayman)'s Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

WuXi Biologics (Cayman)'s Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, WuXi Biologics (Cayman)'s Market Cap distribution charts can be found below:

* The bar in red indicates where WuXi Biologics (Cayman)'s Market Cap falls into.

WuXi Biologics (Cayman) Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

WuXi Biologics (Cayman)'s Market Cap for the fiscal year that ended in Dec. 2022 is calculated as

Market Cap (A: Dec. 2022 )	=	Share Price (A: Dec. 2022 )	*	Shares Outstanding (EOP) (A: Dec. 2022 )
	=	HK$59.85	*	4225.26
	=	HK$252,882

WuXi Biologics (Cayman)'s Market Cap for the quarter that ended in Jun. 2023 is calculated as

Market Cap (Q: Jun. 2023 )	=	Share Price (Q: Jun. 2023 )	*	Shares Outstanding (EOP) (Q: Jun. 2023 )
	=	HK$37.55	*	4248.53
	=	HK$159,532

WuXi Biologics (Cayman) (HKSE:02269) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

WuXi Biologics (Cayman) Market Cap Related Terms

Thank you for viewing the detailed overview of WuXi Biologics (Cayman)'s Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

WuXi Biologics (Cayman) (HKSE:02269) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » WuXi Biologics (Cayman) Inc (HKSE:02269) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

WXIBF:USA WXXWY:USA 2269:Mexico 1FW1:Germany 1FW2:Germany

Address

No. 108, Meiliang Road, Mashan Binhu District, Wuxi, CHN, 214092

Website

https://www.wuxibiologics.com

WuXi Biologics is one of the largest global biologics CRDMOs. WuXi Biologics, incorporated in 2014 following the reorganization of WuXi PharmaTech, later known as WuXi AppTec, now has global revenue of CNY 15 billion. North American represented 55.6% of total revenue in 2022. It adopts the follow and win the molecule strategy by providing end-to-end services, from drug discovery to commercial manufacturing. It also adopts a global dual-sourcing strategy by providing drug products and large-scale drug substance manufacturing.

WuXi Biologics (Cayman) (HKSE:02269) Headlines

No Headlines